101 在COVID-19大流行之前和期间,对培美曲塞一线维持治疗(1LM)和免疫疗法(IO)对缺乏靶向突变的非鳞状(NSQ)晚期/转移性非小细胞肺癌(a/mNSCLC)的影响的真实世界分析

F. Gomes, N. Gilding, V. Tan, K. Christoforou, J. Rule, A. Aziez, Adam Januszewski, A. Minchom
{"title":"101 在COVID-19大流行之前和期间,对培美曲塞一线维持治疗(1LM)和免疫疗法(IO)对缺乏靶向突变的非鳞状(NSQ)晚期/转移性非小细胞肺癌(a/mNSCLC)的影响的真实世界分析","authors":"F. Gomes, N. Gilding, V. Tan, K. Christoforou, J. Rule, A. Aziez, Adam Januszewski, A. Minchom","doi":"10.1016/j.lungcan.2024.107662","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":507097,"journal":{"name":"Lung cancer","volume":"11 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic\",\"authors\":\"F. Gomes, N. Gilding, V. Tan, K. Christoforou, J. Rule, A. Aziez, Adam Januszewski, A. Minchom\",\"doi\":\"10.1016/j.lungcan.2024.107662\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":507097,\"journal\":{\"name\":\"Lung cancer\",\"volume\":\"11 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lung cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.lungcan.2024.107662\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.lungcan.2024.107662","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信